drugset / Trial / NCT00709995
A Study for Participants With Metastatic Renal Cell Carcinoma
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will compare the effects of Enzastaurin plus Sunitinib versus Sunitinib alone in metastatic Renal Cell Cancer.
Timeline
- Start
- 2008-06-30
- Primary completion
- 2010-02-15
- Completion
- 2018-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | enzastaurin | Small molecule | 125 mg | Oral |
| Subject | enzastaurin | Small molecule | 250 mg | Oral |
| Background | Sunitinib | Small molecule | 50 mg | Oral |